Latest papers

Long-lasting cross-presentation of tumor antigen in human DC.

Melanoma Progression Despite Infiltration by In Vivo-primed TRP-2–specific T Cells

Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy.

ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II.

Self-organized criticality theory of autoimmunity.

Limiting dilution analysis of antigen-specific T cells.

Activation of dendritic cells by toll-like receptors and C-type lectins.

Regulation of dendritic- and T-cell fate by injury-associated endogenous signals.

Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.

Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses.

Redundancy renders the glycoprotein 96 receptor scavenger receptor A dispensable for cross priming in vivo.

Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.

NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells.

Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.

Recruitment of Rab27a to phagosomes controls microbial antigen cross-presentation by dendritic cells.

Urea-mediated cross-presentation of soluble Epstein-Barr virus BZLF1 protein.

Absence of the Cellular Prion Protein Exacerbates and Prolongs Neuroinflammation in Experimental Autoimmune Encephalomyelitis

Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo.

Crosspresentation by nonhematopoietic and direct presentation by hematopoietic cells induce central tolerance to myelin basic protein.

Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice.